PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,000 | -99.7% | 2,579 | +175.2% | 0.00% | – |
| Q4 2016 | $1,986,000 | -36.7% | 937 | 0.0% | 0.00% | – |
| Q3 2016 | $3,138,000 | +90.8% | 937 | +78.8% | 0.00% | – |
| Q2 2016 | $1,645,000 | -5.7% | 524 | 0.0% | 0.00% | – |
| Q1 2016 | $1,745,000 | -5.9% | 524 | 0.0% | 0.00% | – |
| Q4 2015 | $1,854,000 | -29.6% | 524 | 0.0% | 0.00% | – |
| Q3 2015 | $2,635,000 | +114.6% | 524 | +174.3% | 0.00% | – |
| Q2 2015 | $1,228,000 | -8.6% | 191 | 0.0% | 0.00% | – |
| Q1 2015 | $1,344,000 | -8.7% | 191 | 0.0% | 0.00% | – |
| Q4 2014 | $1,472,000 | +3.2% | 191 | 0.0% | 0.00% | – |
| Q3 2014 | $1,426,000 | -22.8% | 191 | 0.0% | 0.00% | – |
| Q2 2014 | $1,848,000 | +16.4% | 191 | 0.0% | 0.00% | – |
| Q1 2014 | $1,587,000 | -1.6% | 191 | 0.0% | 0.00% | – |
| Q4 2013 | $1,612,000 | – | 191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |